| Biomarker ID | 1286 |
| PMID | 24391718 |
| Year | 2013 |
| Biomarker | PDCD6IP; UBA52; BCAM; PABPC1; YWHAB; ANXA2; ATP1A1; ATP1B1; ATP1B3; BSG; CLIC1; ITGA6; F11R; ACTA2; ATP12A; CTNNB1; ENO1; HSPA5; KPNB1; PKM2; TPI1; ARF1; CD151; CXADR; HSP90AB3P; IQGAP1; PGK1; PRDX1; RAB10; RAP1A; TUBA1A; UGDH; |
| Biomarker Basis | Expression Based |
| Biomolecule | Protein |
| Source | Cell Lines |
| Subjects | Humans |
| Regulation | Upregulated in VCaP cell lines (log2 fold): Downregulated in VCaP cell lines (log2 fold): [] |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | VCaP vs PNT2C2 |
| Type of Biomarker | Diagnostic |
| Cohort | 2 immortalized primary prostate epithelial cells (PNT2C2 and RWPE- 1) and 2 PCa cell lines (PC346C and VCaP) were chosen for this study |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.05 |
| Method Used | Mass spectrometry |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Selected Genes validated on cell lines by Western Blotting |
| Technical Name | PDCD6IP, UBA52, BCAM, PABPC1, YWHAB, ANXA2, ATP1A1, ATP1B1, ATP1B3, BSG, CLIC1, ITGA6, F11R, ACTA2, ATP12A, CTNNB1, ENO1, HSPA5, KPNB1, PKM2, TPI1, ARF1, CD151, CXADR, HSP90AB3P, IQGAP1, PGK1, PRDX1, RAB10, RAP1A, TUBA1A, UGDH |